Hasan Yusefzadeh; Aziz Rezapour; Farhad Lotfi; Farbod Ebadifard Azar; Bahram Nabilou; Hasan Abolghasem Gorji; Mohammad Reza Hadian; Niusha Shahidi Sadeghi; Atiyeh Karami

Current status of biopharmaceuticals in Iran’s pharmaceutical market

Generics and Biosimilars Initiative Journal 2(1) (2013)

Abdol Majid Cheraghali

Augmenting learning processes of absorptive capacity for innovation: Insights for effective leadership within global pharmaceutical companies

European Management Review 19(2) (2021)

Mohammad Rezaei Zadeh; Ray Hackney; Jing Zeng

Policies to improve access to pharmaceutical products in shortage: the experience of Iran food and drug administration

DARU Journal of Pharmaceutical Sciences 27(1) (2019)

Nazila Yousefi; Najmeh Moradi; Rassoul Dinarvand; Golbarg Ghiasi; H Inanloo; Farzad Peiravian

Biosimilars; a unique opportunity for Iran national health sector and national pharmaceutical industry

DARU Journal of Pharmaceutical Sciences 20(1) (2012)

Abdol Majid Cheraghali

Availability of blood components and plasma derived medicines in Iran

Transfusion and Apheresis Science 37(1) (2007)

Abdol Majid Cheraghali

Trend analysis of medicine consumption based on therapeutic categories in Iran: 2000–2016

Journal of Research in Pharmacy Practice 7(2) (2018)

Abbas Kebriaeezadeh; Alireza Yektadoost; Farid Ebrahimi; Mohammadreza Mashouf; Naghmeh Hadidi; Nasser Nassiri Koopaei

Policies and Practices Catalyzing the Use of Generic Medicines: A Systematic Search and Review

Ethiopian Journal of Health Sciences 31(1) (2021)

Shahmoradi Mostafa; Mosadeghrad Ali Mohammad; Ebrahim Jaafaripooyan

Improving availability and affordability of plasma-derived medicines

Biologicals 38(1) (2010)

Abdol Majid Cheraghali; Hassan Abolghasemi

The impact of sanction and healthcare system reform on the healthcare performance and pharmaceutical market in Iran; 2001-2016

Journal of Pharmaceutical Policy and Practice 13(1) (2020)

Saman Zartab; Nasrin Nassiri Koopaei; Hadi Abbasian; Mansur Nassiri Koopaei; Nasser Nassiri Koopaei

Assessing the Factors Associated With Iran’s Intra-Industry Trade in Pharmaceuticals

Global Journal of Health Science 7(5) (2015)

Hasan Yusefzadeh; Mohammad Reza Hadian; Hasan Abolghasem Gorji; Hossein Ghaderi

Investigating the exposure of Iranian households to catastrophic health expenditure due to the need to purchase medicines

PLoS ONE 14(4) (2019)

Mohammadreza Amiresmaili; Zahra Emrani

Biosimilar Medicines in the Iranian Market: a Way to More Affordable Medicines

Indian Journal of Pharmaceutical Sciences 82(3) (2020)

Nazila Yousefi; Razieh Ahmadi; Hossein Tayeba; S. Taheri; Fereidoon Mahboudi; Farzad Peiravian

Fostering Dynamic Capabilities of SMEs. The Impact of Inward International Licensing on Absorptive Capacity and Networking Capability : A Multiple Case Study in Pharmaceutical Industry

Linköping University Electronic Press eBooks (2014)

Mohammad Reza Saeedi

How does external reference pricing work in developing countries: evidence from Iran

Frontiers in Pharmacology 14 (2023)

Fatemeh Babaie; Mohammad Hossein Motevalli; Gholamhossein Mehralian; Farzad Peiravian; Nazila Yousefi

Pharmaceutical innovation and market share: evidence from a generic market

International Journal of Pharmaceutical and Healthcare Marketing 10(4) (2016)

Nazila Yousefi; Gholamhossein Mehralian; Hamid Reza Rasekh; Hossein Tayeba

The History of Modern Biotechnology in Iran: A Medical Review

Journal of Biotechnology & Biomaterials 03(02) (2013)

Ramin Mazaheri Nezhad Fard

Evaluation of productivity in Iranian pharmaceutical companies: A DEA-based Malmquist approach and panel data analysis

Journal of Research in Pharmacy Practice 4(2) (2015)

Abbas Kebriaeezadeh; Amir Hashemi Meshkini; Vida Varahrami; Mehdi Varmaghani; Saeed Yaghoubifard; Mehdi Yousefi; Hedieh-Sadat Zekri; Majid Annabi; EhsanRezaei Darzi; Farshad Farzadfar